The NSCLC cell expressing EP2 receptors, a key modulator of tumor development, has its mRNA and protein expression significantly attenuated in the presence of PPAR-γ ligands, GW1929, 15D-PGJ2, ciglitazone, troglitazone and rosiglitazone [41]. Here, PPARG is linked to neoplasm.